Indoco Remedies reports 36% fall in Q4 consolidated net profit

23 May 2023 Evaluate

Indoco Remedies has reported results for fourth quarter (Q4) and year ended March 31, 2023.

The company has reported 37.16% fall in net profit at Rs 25.37 crore for the quarter under review as compared to Rs 40.37 crore for the same quarter in the previous year. However, total income of the company increased by 4.59% at Rs 427.95 crore for Q4FY23 as compared to Rs 409.17 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 36.19% fall in its net profit at Rs 25.81 crore for fourth quarter ended March 31, 2023 as compared to Rs 40.45 crore for the same quarter in the previous year. However, total income of the company increased by 4.70% at Rs 428.66 crore for Q4FY23 as compared to Rs 409.43 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported 8.52% fall in its net profit at Rs 141.36 crore as compared to Rs 154.52 crore for the previous year. However, total income of the company increased by 8.23% at Rs 1669.02 crore for year under review as compared to Rs 1542.04 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported 8.11% fall in its net profit at Rs 142.25 crore as compared to Rs 154.80 crore for the previous year. However, total income of the company increased by 8.29% at Rs 1670.95 crore for year under review as compared to Rs 1543.08 crore for year ended March 31, 2022.

Indoco Remedies Share Price

336.85 -0.55 (-0.16%)
06-May-2024 11:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1524.75
Dr. Reddys Lab 6296.05
Cipla 1419.35
Zydus Lifesciences 1000.45
Lupin 1653.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.